Dasher Neuroscience Inc.

This study tests a new drug called YA-101 in 75 people with multiple system atrophy (MSA), a rare brain disease that affects movement and body functions. The goal is to see if the drug is safe and can help control the disease. Participants will receive either YA-101 or a placebo,…